CRYOPORT, INC. Accrued Vacation, Current
CRYOPORT, INC. (CYRX) had Accrued Vacation, Current of $3.35 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Payables and Accruals › Employee-related Liabilities, Current
us-gaap:AccruedVacationCurrent · last filed 2026-03-05
- 2025-12-31: Accrued Vacation, Current $3.35M.
- 2024-12-31: Accrued Vacation, Current $2.93M; Accrued Vacation, Current as first filed $3.06M.
- 2023-12-31: Accrued Vacation, Current $2.77M.
- 2022-12-31: Accrued Vacation, Current $2.45M.
| Period end | Accrued Vacation, Current | Accrued Vacation, Current as first filed |
|---|---|---|
| 2025-12-31 | $3.35M 10-K · filed 2026-03-05 | |
| 2024-12-31 | $2.93M 10-K · filed 2026-03-05 | $3.06M 10-K · filed 2025-03-07 |
| 2023-12-31 | $2.77M 10-K · filed 2025-03-07 | |
| 2022-12-31 | $2.45M 10-K · filed 2024-03-13 | |
| 2021-12-31 | $1.91M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $1.39M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $518.00K 10-K · filed 2021-03-01 | $517.83K 10-K · filed 2020-03-10 |
| 2018-12-31 | $361.68K 10-K · filed 2020-03-10 | |
| 2017-12-31 | $307.53K 10-K · filed 2019-03-13 | |
| 2016-12-31 | $207.03K 10-K · filed 2018-03-08 | |
| 2016-03-31 | $199.19K 10-KT · filed 2017-03-13 | |
| 2015-03-31 | $159.99K 10-K · filed 2016-06-28 | |
| 2014-03-31 | $155.17K 10-K · filed 2015-05-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |